Buzzy Numbing Device Update | Shark Tank Season 5
When kids visit the pediatrician for well visits, the worst part can be the shots. That’s why Dr. Amy Baxter created a novelty numbing device, that she says will take the sting out of childhood immunizations. Will she earn a deal on
Shark Tank Buzzy Update
- Entrepreneurs: Amy Baxter
- Business: Injection site numbing device
- Ask: $500,000 in exchange for 5% equity
- Result: No sharks
- Sharks: None
Dr. Amy, created the Buzzy after her young son had a bad experience while getting his routine immunizations. She discovered that strong vibrations combined with a cold pack, could numb the skin to the point that kids didn’t feel anything.
In the year she appeared on the show, her product was on track to do $1 million in sales, with $660,000 being net profit and $270,000 gross profit. The projection for the next year was $2.5 million in sales. Overall, the company had sold 33,000 units. The entry-level Buzzy for home use retailed for about $40, and the product had an impressive margin of about 70% per unit.
Barbara Corcoran told Amy that getting the device into hospitals and clinics would cost more than she was willing to invest, so she was out. Kevin O’Leary didn’t think the distribution strategy was well thought out. When Robert Herjavec and Mark Cuban questioned her further about her intentions for their investment, it was apparent that Amy hadn’t thought very far ahead.
Lori Greiner said that Amy should be focused more on selling the product to medical clinics and hospitals rather than retail, so she was out. Kevin offered $500,000 in exchange for 20%, to which Amy replied that she already had other offers for $500,000 outside of
Robert said that Kevin’s valuation was correct, and his offer was more realistic than what she was asking for. Robert offered to go in for $250,000 with Kevin, splitting the deal, but Amy rejected the offer.
Mark offered $500,000 in exchange for 20% as well, but Amy declined his offer too. Buzzy went away without a deal, but what happened next for the company? Keep reading our Buzzy update to find out!
We have good news to report in our Buzzy update! The company is still going strong in 2023, with an estimated $1 million in revenue per year. The product line has expanded, offering several drug-free, pain relief options for all ages and needs. With availability on the Buzzy website, products can also be purchased on Amazon, and in select CVS stores.
Would you like to learn about the other companies featured on Season 5 Episode 18? Follow the links below for our other company updates from the episode.
For even more on companies and products, be sure to stop by our Season 5 Products Page!